Synthesis, Inhaltsverzeichnis Synthesis 2012; 44(21): 3392-3398DOI: 10.1055/s-0032-1316777 paper © Georg Thieme Verlag Stuttgart · New York Functionalization of Chromones through an Aza-Baylis–Hillman-Type Reaction Michael A. Terzidis a Department of Chemistry, Laboratory of Organic Chemistry, University of Thessaloniki, 54124 Macedonia, Greece , Vassilios G. Tsiaras a Department of Chemistry, Laboratory of Organic Chemistry, University of Thessaloniki, 54124 Macedonia, Greece , Julia Stephanidou-Stephanatou* a Department of Chemistry, Laboratory of Organic Chemistry, University of Thessaloniki, 54124 Macedonia, Greece , Constantinos A. Tsoleridis* a Department of Chemistry, Laboratory of Organic Chemistry, University of Thessaloniki, 54124 Macedonia, Greece , Vassilis Psycharis b Institute of Materials Science, NCSR Demokritos, 15310 Aghia Paraskevi Attikis, Greece Fax: +30(2310)997679 eMail: ioulia@chem.auth.gr eMail: tsolerid@chem.auth.gr , Catherine P. Raptopoulou b Institute of Materials Science, NCSR Demokritos, 15310 Aghia Paraskevi Attikis, Greece Fax: +30(2310)997679 eMail: ioulia@chem.auth.gr eMail: tsolerid@chem.auth.gr › Institutsangaben Artikel empfehlen Abstract Artikel einzeln kaufen Alle Artikel dieser Rubrik Abstract The synthesis of (N,N′-bisalkoxycarbonyl)hydrazinochromones via the aza-Baylis–Hillman reaction of formylchromones and azodicarboxylates is reported. A plausible mechanistic scheme for the formation of these compounds, involving the chromone formyl group elimination, is proposed. Conformational analysis was performed by DFT calculations. The structure of one example was confirmed by XRD investigation. Full assignment of all 1H and 13C NMR chemical shifts has been unambiguously achieved. Key words Key wordsazodicarboxylates - formylchromones - DABCO - aza-Baylis–Hillman reaction Volltext Referenzen References 1a Yang Y, Xu Y, Xia T, Chen F, Zhang C, Liang W, Lai L, Fang X. Chem. Commun. 2011; 47: 5440 1b Hyz K, Kawecki R, Misior A, Bocian W, Bednarek E, Sitkowski J, Kozerski L. J. Med. Chem. 2011; 54: 8386 1c Gobbi S, Cavalli A, Rampa A, Belluti F, Piazzi L, Paluszcak A, Hartmann RW, Recanatini M, Bisi A. J. Med. Chem. 2006; 49: 4777 1d Nutley BP, Smith NF, Hayes A, Kelland LR, Brunton L, Golding BT, Smith GC. M, Martin NM. B, Workman P, Raynaud FI. Br. J. Cancer 2005; 93: 1011 1e Boumendjel A, Nicolle E, Moraux T, Gerby B, Blanc M, Ronot X, Boutonnat J. J. Med. Chem. 2005; 48: 7275 1f Ahmed-Belkacem A, Pozza A, Muñoz-Martínez F, Bates SE, Castanys S, Gamarro F, Di Pietro A, Pérez-Victoria JM. Cancer Res. 2005; 65: 4852 1g Morris J, Wishka DG, Lin AH, Humphrey WR, Wiltse AL, Gammill RB, Judge TM, Bisaha SN, Olds NL, Jacob CS, Bergh CL, Cudahy MM, Williams DJ, Nishizawa EE, Thomas EW, Gorman RR, Benjamin CW, Shebuski RJ. J. Med. Chem. 1993; 36: 2026 1h Horie T, Tominaga H, Kawamura Y, Hada T, Ueda N, Amano Y, Yamamoto S. J. Med. Chem. 1991; 34: 2169 2a Vedachalam S, Zeng J, Gorityala BK, Antonio M, Liu X.-W. Org. Lett. 2010; 12: 352 2b Dauzonne D, Folléas B, Martinez L, Chabot GG. Eur. J. Med. Chem. 1997; 32: 71 3a Sawada T, Hashimoto S, Tohma S, Nishioka Y, Nagai T, Sato T, Ito K, Inoue T, Iwata M, Yamamoto K. Immunopharmacology 2000; 49: 285 3b Inaba T, Tanaka K, Takeno R, Nagaki H, Yoshida C, Takano S. Chem. Pharm. Bull. 2000; 48: 131 4a Tanaka K, Yamamoto T, Aikawa Y, Kizawa K, Muramoto K, Matsuno H, Muraguchi A. Rheumatology 2003; 42: 1365 4b Kuriyama K, Higuchi C, Tanaka K, Yoshikawa H, Itoh K. Biochem. Biophys. Res. Commun. 2002; 299: 903 4c Aikawa Y, Yamamoto M, Yamamoto T, Morimoto K, Tanaka K. Inflamm. Res. 2002; 51: 188 4d Kawakami A, Tsuboi M, Urayama S, Matsuoka N, Yamasaki S, Hida A, Aoyagi T, Furuichi I, Nakashima T, Migita K, Kawabe Y, Nakashima M, Origuchi T, Eguchi K. J. Lab. Clin. Med. 1999; 133: 566 4e Aikawa Y, Tanuma N, Shin T, Makino S, Tanaka K, Matsumoto Y. J. Neuroimmunol. 1998; 89: 35 5 Quiney C, Dauzonne D, Kern C, Fourneron J.-D, Izard J.-C, Mohammad RM, Kolb J.-P, Billard C. Leukemia Res. 2004; 28: 851 6 Beudot C, De Méo MP, Dauzonne D, Elias R, Laget M, Guiraud H, Balansard G, Duménil G. Mutat. Res. 1998; 417: 141 7 Geissler JF, Roesel JL, Meyer T, Trinks UP, Traxler P, Lydon NB. Cancer Res. 1992; 52: 4492 8a Fridén-Saxin M, Pemberton N, Da Silva Andersson K, Dyrager C, Friberg A, Grøtli M, Luthman K. J. Org. Chem. 2009; 74: 2755 8b Bauvois B, Puiffe M.-L, Bongui J.-B, Paillat S, Monneret C, Dauzonne D. J. Med. Chem. 2003; 46: 3900 8c DeWald HA, Heffner TG, Jaen JC, Lustgarten DM, McPhail AT, Meltzer LT, Pugsley TA, Wise LD. J. Med. Chem. 1990; 33: 445 9a Declerck V, Martinez J, Lamaty F. Chem. Rev. 2009; 109: 1 9b Nair V, Biju AT, Mathew SC, Babu BP. Chem.–Asian J. 2008; 3: 810 9c Shi M, Zhao G.-L. Tetrahedron 2004; 60: 2083 9d Kamimura A, Gunjigake Y, Mitsudera H, Yokoyama S. Tetrahedron Lett. 1998; 39: 7323 10a Basavaiah D, Rao AJ, Satyanarayana T. Chem. Rev. 2003; 103: 811 10b Shi Y.-L, Shi M. Synlett 2005; 2623 10c Shi Y.-L, Shi M. Eur. J. Org. Chem. 2007; 2905 10d Shi Y.-L, Shi M. Org. Biomol. Chem. 2007; 1499 10e Singh V, Batra S. Tetrahedron 2008; 64: 4511 11a Basavaiah D, Rao AJ. Tetrahedron Lett. 2003; 44: 4365 11b Molefe DM, Kaye PT. Synth. Commun. 2009; 39: 3586 12 Wu C, Liu Y, Zeng H, Liu L, Wang D, Chen Y. Org. Biomol. Chem. 2011; 9: 253 13a Terzidis M, Tsoleridis CA, Stephanidou-Stephanatou J. Tetrahedron Lett. 2005; 46: 7239 13b Terzidis M, Tsoleridis CA, Stephanidou-Stephanatou J. Tetrahedron 2007; 63: 7828 13c Zarganes-Tzitzikas T, Terzidis MA, Tsoleridis CA, Stephanidou-Stephanatou J. J. Org. Chem. 2011; 76: 9008 14a Terzidis MA, Stephanidou-Stephanatou J, Tsoleridis CA. Tetrahedron Lett. 2009; 50: 1196 14b Terzidis MA, Stephanidou-Stephanatou J, Tsoleridis CA, Terzis A, Raptopoulou CP, Psycharis V. Tetrahedron 2010; 66: 947 14c Terzidis MA, Tsoleridis CA, Stephanidou-Stephanatou J. J. Org. Chem. 2010; 75: 1948 14d Terzidis MA, Tsiaras VG, Stephanidou-Stephanatou J, Tsoleridis CA. Synthesis 2011; 97 15 Papafilippou A, Terzidis MA, Stephanidou-Stephanatou J, Tsoleridis CA. Tetrahedron Lett. 2011; 52: 1306 16 Terzidis MA, Tsoleridis CA, Stephanidou-Stephanatou J, Terzis A, Raptopoulou CP, Psycharis V. Tetrahedron 2008; 64: 11611 17 Complete crystallographic data for compound 3a have been deposited with the Cambridge Crystallographic Data Centre as supplementary publication No. CCDC 882016. Copies of the data can be obtained free of charge on application to CCDC, 12 Union Road, Cambridge CB2 1EZ, UK; fax: +44(1223)336 033, e-mail: deposit@ccdc.cam.ac.uk 18 Frisch MJ, Trucks GW, Schlegel HB, Scuseria GE, Robb MA, Cheeseman JR, Montgomery JA. Jr, Vreven T, Kudin KN, Burant JC, Millam JM, Iyengar SS, Tomasi J, Barone V, Mennucci B, Cossi M, Scalmani G, Rega N, Petersson GA, Nakatsuji H, Hada M, Ehara M, Toyota K, Fukuda R, Hasegawa J, Ishida M, Nakajima T, Honda Y, Kitao O, Nakai H, Klene M, Li X, Knox JE, Hratchian HP, Cross JB, Bakken V, Adamo C, Jaramillo J, Gomperts R, Stratmann RE, Yazyev O, Austin AJ, Cammi R, Pomelli C, Ochterski JW, Ayala PY, Morokuma K, Voth GA, Salvador P, Dannenberg JJ, Zakrzewski VG, Dapprich S, Daniels AD, Strain MC, Farkas O, Malick DK, Rabuck AD, Raghavachari K, Foresman JB, Ortiz JV, Cui Q, Baboul AG, Clifford S, Cioslowski J, Stefanov BB, Liu G, Liashenko A, Piskorz P, Komaromi I, Martin RL, Fox DJ, Keith T, Al-Laham MA, Peng CY, Nanayakkara A, Challacombe M, Gill PM. W, Johnson B, Chen W, Wong MW, Gonzalez C, Pople JA. Gaussian03, rev. E.01 11-Sep-2007 . Gaussian, Inc; Wallingford CT: 2004 19a Cancès MT, Mennucci B, Tomasi J. J. Chem. Phys. 1997; 107: 3032 19b Cossi M, Barone V, Mennucci B, Tomasi J. Chem. Phys. Lett. 1998; 286: 253 19c Mennucci B, Tomasi J. J. Chem. Phys. 1996; 106: 5151 Zusatzmaterial Zusatzmaterial Supporting Information
